Article
A scalable metabolite supplementation strategy against antibiotic resistant pathogen Chromobacterium violaceum induced by NAD+/NADH+ imbalance.
BMC systems biology - 26 Apr 2017
Banerjee Deepanwita, Parmar Dharmeshkumar, Bhattacharya Nivedita, Ghanate Avinash D, Panchagnula Venkateswarlu, Raghunathan Anu
Abstract excerpt
BACKGROUND: The leading edge of the global problem of antibiotic resistance necessitates novel therapeutic strategies. This study develops a novel systems biology driven approach for killing antibiotic resistant pathogens using benign metabolites. RESULTS: Controlled laboratory evolutions established chloramphenicol and streptomycin resistant pathogens of Chromobacterium. These resistant pathogens showed higher...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
